Generic Products

Generic Products

The first generic medicine we ever made? Penicillin G in 1966. Since then, Mylan has applied one global quality standard across our facilities, and across our product line, regardless of market.

How We Make Generic Medicines at Mylan

  1. Drug Monitoring
    1961

    Advanced Monitoring Systems

    Although not required, Mylan utilizes state-of-the-art monitoring systems that can automatically evaluate and reject a product that does not meet specifications. This advanced technology is used to automatically remove a defective product from production or packaging lines.

  2. Drug Standards
    1965

    One Global Quality Standard

    Whether it’s a medication for millions or for a handful of people, our priorities are to meet or exceed industry standards. Our own teams conduct ongoing reviews to ensure quality and integrity of products, start to finish, and to continually improve for optimal quality and consistency. Because trust goes beyond our global quality standards. It’s all about caring for the people who will be helped by what we do.

  3. Protection Against Defects
    1966

    Protection Against Defects

    Quality begins at step one. Mylan uses an established testing and verification process to ensure the suitability of active ingredients used in our medicines.

  4. Proof of Purity and Potency
    1969

    Proof of Purity and Potency

    Mylan assures product potency, purity and drug release through expiration date by testing the stability of our products at specific intervals.

  5. A Commitment to Pharmacists
    1972

    A Promise to Pharmacists

    Customers count on you for advice. That's one of the reasons Mylan applies one global quality standard across our facilities and across our product line, regardless of market.

  6. A Commitment to Physicians
    1976

    A Promise to Physicians

    To ensure that you provide your patients with the highest quality medicines, Mylan uses advanced testing and monitoring systems to assure product adheres to testing acceptance criteria that are in alignment with requirements established by standard-setting organizations around the world.

  • Access Channels

    When your mission is to provide 7 billion people access to high quality medicine, how do you get the medicine to them?

    At Mylan, we’ve established a broad network of local and global access channels through physicians, institutions, governments, retailers and wholesalers. These are relationships we’ve built and nurtured over decades.
  • 3 Facts

    Eigthy-six percent of U.S. prescriptions are filled with a generic medicine.

    One out of every 13 U.S.prescriptions dispensed, brand name or generic, is filled with a Mylan product.

    Generic medicines saved the U.S. healthcare system an estimated $1.2 trillion from 2003 to 2012.
  • Our Generics History

    1970s: By decade’s end, we produced five of the 10 most prescribed generic medicines.

    1981: Mylan helps found the Generic Pharmaceutical Industry Association. The group lobbies for the Hatch-Waxman Act—a response to the high price of brand name drugs.

    1989: Through congressional testimony, we help expose fraudulent practices between the Food and Drug Administration and several generics companies.

    2007: We acquire Merck KGaA’s generics business, which sells products in more than 90 countries.

    2012: We help drive the Generic Drug User Fee Amendments and the Food and Drug Administration Safety and Innovation Act. Both help ensure one global quality standard for all medicines entering the United States.

Latest From Mylan

  1. 0

    Tolterodine Tartrate Extended-release Capsule

    Click here for Full Prescribing Information

    Strengths: 2 mg, 4 mg

    NDC: 0378-3402-93, 0378-3402-77, 0378-3402-05, 0378-3404-93,
    0378-3404-77, 0378-3404-05

    Pack Size: 30, 90, 500

    Launch Date: January 6, 2014
  2. 0

    Mycophenolic Acid Delayed-release Tablets

    Click here for Full Prescribing information including Boxed WARNING for Mycophenolic Acid Delayed-release Tablets

    Strengths: 180 mg, 360 mg

    NDC: 0378-4201-78, 0378-4202-78

    Pack Size: 120

    Launch Date: January 8, 2014
  3. 0

    Repaglinide Tablets, USP

    Click here for Full Prescribing Information

    Strengths: 1 mg, 2 mg

    NDC: 0378-3122-01, 0378-3123-01

    Pack Size: 100

    Launch Date: January 22, 2014
  4. 0

    Telmisartan and Hydrochlorothiazide Tablets, USP

    Click here for Full Prescribing Information including Boxed WARNING for Telmisartan and Hydrochlorothiazide Tablets, USP

    Strengths: 40 mg / 12.5 mg, 80 mg / 12.5 mg, 80 mg / 25 mg

    NDC: 0378-2901-93, 0378-2901-77, 0378-2902-93, 0378-2902-77, 0378-2903-93, 0378-2903-77

    Pack Size: 30, 90

    Launch Date: March 6, 2014
  5. 0

    Eszopiclone Tablets, CIV

    Click here for Full Prescribing Information

    Strengths: 1 mg, 2 mg, 3 mg

    NDC: 0378-5270-01, 0378-5271-01, 0378-5271-10, 0378-5272-01, 0378-5272-10


    Pack Size: 100, 1000

    Launch Date: April 15, 2014

  6. 0

    Xulane® (Norelgestromin and ethinyl estradiol transdermal system)

    Click here for Full Prescribing Information including Boxed WARNING for Xulane®

    Strengths: 150 mcg / 35 mcg per day

    NDC: 0378-3340-53

    Pack Size: 3

    Launch Date: April 16, 2014

    Website: www.Xulane.com
  7. 0

    Olanzapine Orally Disintegrating Tablets

    Click here for Full Prescribing Information including Boxed WARNING for Olanzapine Orally Disintegrating Tablets

    Strengths: 5 mg, 10 mg, 15 mg, 20 mg

    NDC: 0378-5510-93, 0378-5511-93, 0378-5512-93, 0378-5513-93

    Pack Size: 30

    Launch Date: May 12, 2014
  8. 0

    Atovaquone and Proguanil Hydrochloride Tablets

    Click here for Full Prescribing Information

    Strengths: 62.5 mg / 25 mg, 250 mg / 100 mg

    NDC: 0378-4160-01, 0378-4162-01

    Pack Size: 100

    Launch Date: May 28, 2014
  9. 0

    Risedronate Sodium Tablets, USP

    Click here for Full Prescribing Information

    Strengths: 150 mg

    NDC: 0378-4150-32, 0378-4150-53

    Pack Size: 1, 3

    Launch Date: June 10, 2014
  10. 0

    Tamoxifen Citrate Tablets, USP

    Click here for Full Prescribing Information including Boxed WARNING for Tamoxifen Citrate Tablets, USP

    Strengths: 10 mg, 20 mg

    NDC: 0378-0144-91, 0378-0274-93, 0378-0274-01

    Pack Size: 60, 30, 100

    Launch Date: June 13, 2014
  11. 0

    Ziprasidone Hydrochloride Capsules

    Click here for Full Prescribing Information including Boxed WARNING for Ziprasidone Hydrochloride Capsules

    Strengths: 20 mg, 40 mg, 60 mg, 80 mg

    NDC: 0378-7350-91, 0378-7350-05, 0378-7351-91, 0378-7351-05, 0378-7352-91, 0378-7352-05, 0378-7353-91, 0378-7353-05

    Pack Size: 60, 500

    Launch Date: June 24, 2014
  12. 0

    Doxycycline Hyclate Tablets, USP

    Click here for Full Prescribing Information

    Strengths: 100 mg

    NDC: 0378-0167-89, 0378-0167-05

    Pack Size: 50, 500

    Launch Date: June 26, 2014
  13. 0

    Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1 mg/0.02mg

    Click here for Full Prescribing Information for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1mg/0.02mg

    Strengths: 0.1 mg/0.02 mg

    NDC: 0378-7287-53

    Pack Size: 84

    Launch Date: June 26, 2014
  14. 0

    Telmisartan Tablets, USP

    Click here for Full Prescribing Information for Telmisartan Tablets, USP

    Strengths: 20 mg, 40 mg, 80 mg

    NDC: 0378-2920-93, 0378-2920-77, 0378-2921-93, 0378-2921-77, 0378-2922-93, 0378-2922-77

    Pack Size: 30, 90

    Launch Date: July 7, 2014
  15. 0

    Doxycycline Hyclate Capsules, USP

    Click here for Full Prescribing Information

    Strengths: 50 mg, 100 mg

    NDC: 0378-0145-89, 0378-0148-89, 0378-0148-05

    Pack Size: 50, 500

    Launch Date: July 8, 2014
  16. 0

    Norethindrone Acetate and Ethinyl Estradiol Tablets, USP

    Click here for Full Prescribing Information for Norethindrone Acetate and Ethinyl Estradiol Tablets, USP 1 mg/0.02 mg

    Strengths: 1 mg/0.02 mg

    NDC: 0378-7280-53

    Pack Size: 63

    Launch Date: July 11, 2014
  17. 0

    Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate Tablets, 75mg

  18. 0

    Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP, 0.15 mg/0.02 mg + 0.01 mg

Why Generics?

Because there is nothing generic about our standards. Our internal teams conduct reviews of all products, start to finish, no matter where in the world they are made.
Resources and information to help prescribe, dispense and take medicine with confidence

Pharmacists

Educational materials to help empower your customers

Patients

What to know about our high quality generics

Physicians

Details about our brand name and generic medicines

Institutional Customers

Resources that meet the specific needs of your institution

Institutional Products


We are committed to offering a complete line of reliable, high quality products that are designed to help hospitals and other institutions reduce error, increase efficiency and improve care.

What we offer